Evotec SE (EVO) stock
EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.46−0.02 (-1.35%)
Close on Nov 18, 2026Market cap $519.11MP/E –Yield –
Evotec pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Evotec's pe ratio was 12.9× on Feb 28, 2023, against 653.5× a year earlier. Over the last 3 years it ranged from 11.6× to 962.8×, with a median of 91.0×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Feb 28, 2023 | 12.9× | +1.3 |
| 2022 | Dec 30, 2022 | 11.6× | −847.8 |
| 2021 | Jul 30, 2021 | 859.4× | +739.4 |
| 2020 | Dec 31, 2020 | 120.0× | – |
See a number that looks wrong?